Is Tenable Stock a Buy, Sell or Hold?
Tenable (NASDAQ:TENB) is a cybersecurity company with a focus on…
Buy
73
BRK.TO Quote, Financials, Valuation and Earnings
Last price:
$39.08
Seasonality move
:
-2.47%
Day range:
$39.08 - $39.79
52-week range:
$30.16 - $39.79
Dividend yield:
0%
P/E ratio:
12.54x
P/S ratio:
2.63x
P/B ratio:
1.64x
Volume:
96.7K
Avg. volume:
57.8K
1-year change:
23.75%
Market cap:
$1.5T
Revenue:
$580.2B
EPS (TTM):
$3.12
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Berkshire Hathaway has -- downside to fair value with a price target of -- per share.
BRK.TO vs. S&P 500
-
Over the past 5 trading days, Berkshire Hathaway has overperformed the S&P 500 by 0.65% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Berkshire Hathaway does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Berkshire Hathaway revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Berkshire Hathaway reported revenues of $141.2B.
Earnings Growth
-
Berkshire Hathaway earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Berkshire Hathaway reported earnings per share of $0.70.
Enterprise value:
1.2T
EV / Invested capital:
1.11x
Price / LTM sales:
2.63x
EV / EBIT:
7.78x
EV / Revenue:
2.12x
PEG ratio (5yr expected):
0.23x
EV / Free cash flow:
77.50x
Price / Operating cash flow:
96.18x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
8.03%
Net Income Margin (TTM):
20.99%
Return On Equity:
14.65%
Return On Invested Capital:
12.16%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $306.9B | $593.7B | $580.5B | $177.2B | $141.2B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -$0.70 | $3.30 | $3.12 | $1.30 | $0.70 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $222B | $237.4B | $239.9B | $290.3B | $549B | |
| Total Assets | $1.1T | $1.2T | $1.3T | $1.4T | $1.7T | |
| Current Liabilities | $4.3B | $3B | $3.3B | $7.1B | $21.8B | |
| Total Liabilities | $538.6B | $565.7B | $633.2B | $662B | $720.7B | |
| Total Equity | $575.5B | $656.2B | $653.4B | $756.9B | $935.1B | |
| Total Debt | $149B | $145.6B | $166.5B | $170.1B | $179B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $48.5B | $66.4B | $41.8B | $19.7B | $6.4B | |
| Cash From Investing | -$113.8B | -$44.1B | -$14.1B | -$10.1B | $5.8B | |
| Cash From Financing | -$2.2B | -$19.4B | -$14.2B | -$296.1M | $2.2B | |
| Free Cash Flow | $28.4B | $40.2B | $15.9B | $11.9B | -$951.4M | |
BRK.TO
Sector
Market Cap
$1.5T
--
Price % of 52-Week High
98.22%
--
Dividend Yield
0%
--
Shareholder Yield
0.16%
--
1-Year Price Total Return
23.75%
--
Beta (5-Year)
--
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$38.79
200-day SMA
Buy
Level
$34.44
Bollinger Bands (100)
Buy
Level
34.14 - 37.04
Chaikin Money Flow
Buy
Level
4M
20-day SMA
Buy
Level
$37.93
Relative Strength Index (RSI14)
Buy
Level
65.44
ADX Line
Buy
Level
31.11
Williams %R
Neutral
Level
-22.8296
50-day SMA
Buy
Level
$36.26
MACD (12, 26)
Buy
Level
0.87
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Neutral
Level
3.2M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.0056)
Buy
CA Score
(Annual)
Level (0.3534)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-3.7746)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Berkshire Hathaway is a holding company with a wide array of subsidiaries engaged in diverse activities. The firm's core business segment is insurance, run primarily through Geico, Berkshire Hathaway Reinsurance Group, and Berkshire Hathaway Primary Group. Berkshire has used the excess cash thrown off from these and its other operations over the years to acquire Burlington Northern Santa Fe (railroad), Berkshire Hathaway Energy (utilities and energy distributors), and the companies that make up its manufacturing, service, and retailing operations (which include five of Berkshire's largest noninsurance pretax earnings generators: Precision Castparts, Lubrizol, Clayton Homes, Marmon, and IMC/ISCAR). The conglomerate is unique in that it is run on a completely decentralized basis.
Stock Forecast FAQ
In the current month, BRK.TO has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BRK.TO average analyst price target in the past 3 months is --.
-
Where Will Berkshire Hathaway Stock Be In 1 Year?
According to analysts, the consensus estimate is that Berkshire Hathaway share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Berkshire Hathaway?
Analysts are divided on their view about Berkshire Hathaway share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Berkshire Hathaway is a Sell and believe this share price will rise from its current level to --.
-
What Is Berkshire Hathaway's Price Target?
The price target for Berkshire Hathaway over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is BRK.TO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Berkshire Hathaway is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of BRK.TO?
You can purchase shares of Berkshire Hathaway via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Berkshire Hathaway shares.
-
What Is The Berkshire Hathaway Share Price Today?
Berkshire Hathaway was last trading at $39.08 per share. This represents the most recent stock quote for Berkshire Hathaway. Yesterday, Berkshire Hathaway closed at $39.08 per share.
-
How To Buy Berkshire Hathaway Stock Online?
In order to purchase Berkshire Hathaway stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
